antibody fragment targeting fibronectin edb (China National Nuclear Corporation)
86
Structured Review
China National Nuclear Corporation
antibody fragment targeting fibronectin edb
Antibody Fragment Targeting Fibronectin Edb, supplied by China National Nuclear Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fibronectin/antibody+edb+fibronectin+fragment+targeting/pm42119207-2-4-44
Average 86 stars, based on 1 article reviews
Antibody Fragment Targeting Fibronectin Edb, supplied by China National Nuclear Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fibronectin/antibody+edb+fibronectin+fragment+targeting/pm42119207-2-4-44
Average 86 stars, based on 1 article reviews
antibody fragment targeting fibronectin edb - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
Diagnostic Assay:Article Title: Preclinical evaluation of the antibody fragment targeting fibronectin EDB in the theranostics of radioactive iodine-resistant thyroid cancer. Article Snippet: Objective: Radioactive iodine-resistant thyroid cancer (RAIR-TC) poses diagnostic and therapeutic challenges due to the absence of sodium/iodide symporter (NIS) expression.. This study aims to evaluate the preclinical value of 89Zr-DFO-EDB and 177Lu-DTPA-EDB, an antibody fragment targeting fibronectin EDB (FN-EDB), in the thera- Expressing:Article Title: Preclinical evaluation of the antibody fragment targeting fibronectin EDB in the theranostics of radioactive iodine-resistant thyroid cancer. Article Snippet: Objective: Radioactive iodine-resistant thyroid cancer (RAIR-TC) poses diagnostic and therapeutic challenges due to the absence of sodium/iodide symporter (NIS) expression.. This study aims to evaluate the preclinical value of 89Zr-DFO-EDB and 177Lu-DTPA-EDB, an antibody fragment targeting fibronectin EDB (FN-EDB), in the thera- |